Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Experimental Medicine|November 6, 2023
Stem cell-like reprogramming is required for leukemia-initiating activity in B-ALLVincent Fregona, Manon Bayet, Mathieu Bouttier, et al.
Blood Cancer Journal|May 31, 2024
Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry studyCamille Gondran, Pierre-Yves Dumas, Emilie Bérard, et al.
Haematologica|February 2, 2023
Somatic genetic alterations predict hematological progression in GATA2 deficiencyLaetitia Largeaud, Matthew Collin, Nils Monselet, et al.
Blood Cancer Journal|August 16, 2022
Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemiaFrançois Vergez, Laetitia Largeaud, Sarah Bertoli, et al.
Leukemia|September 18, 2020
Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO studyLaetitia Largeaud, Pascale Cornillet-Lefebvre, Jean-François Hamel, et al.
Blood Advances|September 9, 2025
Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignanciesMichael Loschi, Marie-Charlotte Villy, Jacques-Emmanuel Galimard, et al.
Blood Advances|October 12, 2021
The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11Marina Lafage-Pochitaloff, Bastien Gerby, Véronique Baccini, et al.
The Journal of Clinical Investigation|October 15, 2024
Autoinflammation in patients with leukocytic CBL loss of heterozygosity is caused by constitutive ERK-mediated monocyte activationJonathan Bohlen, Ivan Bagarić, Taja Vatovec, et al.
Nature Immunology|January 16, 2026
Somatic deficiency of the human E3 ubiquitin ligase CBL in leukocytes impairs B cell but not T cell development and functionTaja Vatovec, Anna-Lena Neehus, Katherine J L Jackson, et al.
Pageof 4